A radiopharmaceutical enhances CAR T cells against radio-sensitive and radio-resistant neuroblastoma by tumor sensitization and TME remodeling. - Rodriguez C; Edinger RS; Diehl G; Reyes-González JM; Lee W; Buckley J; Oh J; Nambiar D; Baidoo K; Okada R; Phadke I; Schmiechen Z; et al. (Cell reports. Medicine, 2026)